Beaumont Financial Partners LLC Grows Position in Danaher Co. (NYSE:DHR)

Beaumont Financial Partners LLC lifted its holdings in shares of Danaher Co. (NYSE:DHRGet Rating) by 2.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 50,032 shares of the conglomerate’s stock after buying an additional 1,265 shares during the period. Danaher makes up 1.1% of Beaumont Financial Partners LLC’s portfolio, making the stock its 24th biggest position. Beaumont Financial Partners LLC’s holdings in Danaher were worth $14,682,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Dixon Hughes Goodman Wealth Advisors LLC purchased a new position in Danaher in the fourth quarter worth about $29,000. RFG Advisory LLC boosted its position in Danaher by 2.5% in the fourth quarter. RFG Advisory LLC now owns 5,888 shares of the conglomerate’s stock worth $1,937,000 after purchasing an additional 145 shares during the last quarter. Oak Family Advisors LLC bought a new position in shares of Danaher in the fourth quarter worth about $268,000. Migdal Insurance & Financial Holdings Ltd. raised its stake in shares of Danaher by 103.6% in the fourth quarter. Migdal Insurance & Financial Holdings Ltd. now owns 285 shares of the conglomerate’s stock worth $94,000 after buying an additional 145 shares during the period. Finally, TFC Financial Management raised its stake in shares of Danaher by 20.9% in the fourth quarter. TFC Financial Management now owns 1,158 shares of the conglomerate’s stock worth $381,000 after buying an additional 200 shares during the period. 78.42% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on DHR shares. Barclays raised their price objective on Danaher from $290.00 to $310.00 in a research note on Friday, July 22nd. StockNews.com raised Danaher from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 30th. Evercore ISI decreased their price objective on Danaher from $320.00 to $280.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 5th. KeyCorp decreased their target price on Danaher from $345.00 to $325.00 and set an “overweight” rating on the stock in a research note on Friday, July 22nd. Finally, Wells Fargo & Company downgraded Danaher from an “overweight” rating to an “equal weight” rating and decreased their target price for the company from $330.00 to $265.00 in a research note on Monday, April 25th. One equities research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Danaher has an average rating of “Buy” and a consensus price target of $328.58.

Danaher Trading Up 0.4 %

Shares of Danaher stock traded up $1.05 on Friday, reaching $290.00. The company had a trading volume of 1,316,343 shares, compared to its average volume of 2,304,426. The firm has a market cap of $210.96 billion, a price-to-earnings ratio of 34.16, a P/E/G ratio of 2.32 and a beta of 0.86. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.75 and a quick ratio of 1.32. The firm’s 50-day moving average price is $261.98 and its two-hundred day moving average price is $268.32. Danaher Co. has a 1 year low of $233.71 and a 1 year high of $333.96.

Danaher (NYSE:DHRGet Rating) last announced its earnings results on Thursday, July 21st. The conglomerate reported $2.76 EPS for the quarter, topping analysts’ consensus estimates of $2.35 by $0.41. The firm had revenue of $7.75 billion during the quarter, compared to analysts’ expectations of $7.29 billion. Danaher had a return on equity of 18.57% and a net margin of 20.61%. The company’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.46 EPS. As a group, research analysts predict that Danaher Co. will post 10.39 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 29th. Investors of record on Friday, June 24th were issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date of this dividend was Thursday, June 23rd. Danaher’s payout ratio is currently 11.78%.

Insider Activity at Danaher

In related news, EVP Joakim Weidemanis sold 12,000 shares of the business’s stock in a transaction on Monday, July 25th. The stock was sold at an average price of $271.13, for a total transaction of $3,253,560.00. Following the completion of the transaction, the executive vice president now owns 74,398 shares in the company, valued at approximately $20,171,529.74. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Danaher news, EVP Joakim Weidemanis sold 12,000 shares of Danaher stock in a transaction on Monday, July 25th. The stock was sold at an average price of $271.13, for a total transaction of $3,253,560.00. Following the completion of the sale, the executive vice president now directly owns 74,398 shares of the company’s stock, valued at approximately $20,171,529.74. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Walter G. Lohr sold 3,906 shares of Danaher stock in a transaction on Friday, July 22nd. The shares were sold at an average price of $273.84, for a total value of $1,069,619.04. Following the sale, the director now directly owns 12,115 shares of the company’s stock, valued at $3,317,571.60. The disclosure for this sale can be found here. 11.20% of the stock is owned by company insiders.

Danaher Company Profile

(Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRGet Rating).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.